1 / 21

TOC-Global Organ Transplant Diagnostics Market

Organ transplant diagnostics is one of the most rapidly developing and dynamic industries, and we predict that it will grow at a CAGR of 10.92% between the years 2021 and 2031.<br>Currently, the organ transplant diagnostics industry is witnessing an upsurge due to the rising number of organ transplant procedures, strategic initiatives by key market players, and favorable regulatory scenarios are some of the critical factors which are expected to bolster the market growth.<br><br>

swati8
Download Presentation

TOC-Global Organ Transplant Diagnostics Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. res Organ Transplant Diagnostics Market - A Global and Regional Analysis Table of Content Attribution: https://pixabay.com/photos/tire-rim-car-mechanic-114259/ Organ Transplant Diagnostics Market Focus on Offering, Transplant, Application Technology, End User, and Region Analysis and Forecast: 2021-2031 September 2021 1 All rights reserved at BIS Research Inc.

  2. BIS Research is a leading market intelligence and technology research company. BIS Research publishes in- depth market intelligence reports focusing on the market estimations, technology analysis, emerging high- growth applications, deeply segmented granular country-level market data and other important market parameters useful in the strategic decision making for senior management. BIS Research provides multi-client reports, company profiles, databases, and custom research services. Organ Transplant Diagnostics Market Copyright © 2021 BIS Research Inc. All Rights Reserved. This document contains highly confidential information and is the sole property of BIS Research. Disclosing, copying, circulating, quoting, or otherwise reproducing any or all contents of this document is strictly prohibited. Access to this information is provided exclusively for the benefit of the people or organization concerned. It may not be accessed by or offered whether for sale or otherwise to any third party. 2 All rights reserved at BIS Research Inc.

  3. Table of Content Executive Summary ........................................................................ 21 Research Methodology ................................................................... 27 1.Markets .................................................................................... 32 1.1 Product Definition ............................................................................................ 33 1.1.1Inclusion and Exclusion ............................................................................. 33 1.2 Market Scope ................................................................................................... 33 1.2.1Scope of the Study ...................................................................................... 33 1.2.2Key Questions Answered in the Report .................................................... 34 1.3 Market Overview .............................................................................................. 35 1.3.1Market Definition ......................................................................................... 35 1.3.2Emerging Applications of Organ Transplant Diagnostics ....................... 35 1.3.3Market Footprint and Growth Potential, $Million, 2020-2031 ................... 36 1.3.4COVID-19 Impact on the Global Organ Transplant Diagnostics Market ........................................................................................................... 36 2.Industry Insights ....................................................................... 38 2.1 Overview ........................................................................................................... 39 2.2 Legal Requirements and Framework in the U.S. ........................................... 39 2.2.1FDA Regulation............................................................................................ 39 2.2.2CMS Regulation ........................................................................................... 40 Organ Transplant Diagnostics Market 2.3 Legal Requirements and Frameworks in Europe .......................................... 40 2.4 Legal Requirements and Frameworks in Asia-Pacific .................................. 41 2.4.1China ............................................................................................................ 41 2.4.2Japan ............................................................................................................ 42 2.5 Reimbursement Analysis ................................................................................ 42 3.Market Dynamics ...................................................................... 44 3 All rights reserved at BIS Research Inc.

  4. 3.1 Overview ........................................................................................................... 45 3.2 Impact Analysis ............................................................................................... 45 3.3 Market Drivers .................................................................................................. 46 3.3.1Rising Number of Organ Transplant Procedure ....................................... 46 3.3.2Strategic Initiatives by Key Market Players ............................................... 47 3.3.3Favorable Regulatory Scenario .................................................................. 48 3.4 Market Restraints ............................................................................................. 49 3.4.1High Cost of Organ Transplant Procedure and Diagnostics ................... 49 3.4.2Lack of Knowledge Dissemination and Reluctance Toward Organ Transplants .................................................................................................. 49 3.5 Market Opportunities ....................................................................................... 50 3.5.1Technological Advancement in Transplant Diagnostics ......................... 50 3.5.1.1 Emergence of Nucleic Acid Amplification Testing (NAAT) ................................ 50 3.5.1.2 Growing Focus on Molecular HLA Typing ........................................................ 50 3.5.2Increasing Awareness Regarding Transplants in High potential Market ........................................................................................................... 51 4.Competitive Landscape ............................................................ 52 4.1 Overview ........................................................................................................... 53 4.2 Synergistic Activities ...................................................................................... 53 4.3 Product Launches ........................................................................................... 54 4.4 Product Approvals ........................................................................................... 55 Organ Transplant Diagnostics Market 4.5 Mergers and Acquisitions ............................................................................... 55 4.6 Other Business Activities ............................................................................... 56 4.7 Market Share Analysis, 2019-2020 ................................................................. 57 4.8 Growth Share Analysis (Company) ................................................................ 58 5.Offering, $Million, 2020-2031 .................................................... 60 5.1 Overview ........................................................................................................... 61 4 All rights reserved at BIS Research Inc.

  5. 5.2 Products ........................................................................................................... 62 5.2.1Kits and Assays ........................................................................................... 63 5.2.2Consumables ............................................................................................... 64 5.3 Services ............................................................................................................ 66 6.Transplant, $Million, 2020-2031 ................................................ 68 6.1 Overview ........................................................................................................... 69 6.2 Solid Organ Transplant ................................................................................... 70 6.2.1Kidney .......................................................................................................... 71 6.2.2Liver .............................................................................................................. 73 6.2.3Heart ............................................................................................................. 74 6.2.4Lung .............................................................................................................. 75 6.2.5Pancreas ...................................................................................................... 76 6.2.6Kidney-Pancreas ......................................................................................... 77 6.2.7Other Solid Organs ...................................................................................... 78 6.3 Stem Cell Transplant ....................................................................................... 78 7.Application, $Million, 2020-2031 ............................................... 80 7.1 Overview ........................................................................................................... 81 7.2 Diagnostics ...................................................................................................... 82 7.2.1Donor Testing .............................................................................................. 84 7.2.1.1 Infectious Disease ............................................................................................ 85 7.2.1.1.1Viral .......................................................................................................................... 86 Organ Transplant Diagnostics Market 7.2.1.1.2Bacterial ................................................................................................................... 87 7.2.1.1.3Fungal ...................................................................................................................... 88 7.2.1.1.4Parasitic ................................................................................................................... 89 7.2.1.2 Human Leukocyte Antigen (HLA) Typing .......................................................... 90 7.2.1.3 ABO Grouping .................................................................................................. 91 7.2.2Recipient Testing......................................................................................... 92 5 All rights reserved at BIS Research Inc.

  6. 7.2.2.1 Infectious Disease ............................................................................................ 94 7.2.2.1.1Viral .......................................................................................................................... 95 7.2.2.1.2Bacterial ................................................................................................................... 96 7.2.2.1.3Fungal ...................................................................................................................... 97 7.2.2.1.4Parasitic ................................................................................................................... 98 7.2.2.2 Human Leukocyte Antigen (HLA) Typing .......................................................... 99 7.2.2.3 ABO Grouping ................................................................................................ 100 7.2.2.4 Chimerism Testing ......................................................................................... 100 7.2.2.5 Graft versus Host Disease (GvHD) ................................................................. 101 7.3 Translational Research ................................................................................. 102 8.Technology, $Million, 2020-2031 ............................................. 104 8.1 Overview ......................................................................................................... 105 8.2 Molecular Technologies ................................................................................ 106 8.2.1Polymerase Chain Reaction (PCR) .......................................................... 108 8.2.1.1 Real-Time PCR (RT-PCR) ............................................................................. 109 8.2.1.2 Digital PCR (dPCR) ........................................................................................ 110 8.2.2Sequencing ................................................................................................ 112 8.2.2.1 Next-Generation Sequencing (NGS) .............................................................. 113 8.2.2.2 Sanger Sequencing ........................................................................................ 114 8.2.2.3 Other Molecular Technologies ........................................................................ 115 8.3 Serology ......................................................................................................... 117 8.4 Flow Cytometry (FCM) ................................................................................... 118 Organ Transplant Diagnostics Market 8.5 Other Technologies ....................................................................................... 119 9.End-User, $Million, 2020-2031 ................................................... 121 9.1 Overview ......................................................................................................... 122 9.2 Hospitals and Transplant Centers ................................................................ 123 9.3 Academic and Research Institutions ........................................................... 124 9.4 Reference Laboratories ................................................................................. 125 6 All rights reserved at BIS Research Inc.

  7. 9.5 Other End Users ............................................................................................ 127 10.Regions, $Million, 2020-2031 .................................................. 128 10.1Overview ......................................................................................................... 129 10.2North America ................................................................................................ 133 10.2.1U.S. ............................................................................................................. 135 10.2.2Canada ....................................................................................................... 136 10.3Europe ............................................................................................................ 138 10.3.1Germany ..................................................................................................... 140 10.3.2France ......................................................................................................... 141 10.3.3U.K. ............................................................................................................. 142 10.3.4Italy ............................................................................................................. 143 10.3.5Spain ........................................................................................................... 144 10.3.6Switzerland ................................................................................................ 145 10.3.7Rest-of-Europe........................................................................................... 146 10.4Asia-Pacific .................................................................................................... 148 10.4.1China .......................................................................................................... 150 10.4.2India ............................................................................................................ 151 10.4.3Japan .......................................................................................................... 152 10.4.4South Korea ............................................................................................... 153 10.4.5Australia ..................................................................................................... 154 10.4.6Singapore ................................................................................................... 155 Organ Transplant Diagnostics Market 10.4.7Rest-of-Asia-Pacific (RoAPAC) ................................................................ 156 10.5Latin America ................................................................................................. 157 10.5.1Brazil ........................................................................................................... 159 10.5.2Mexico ........................................................................................................ 160 10.5.3Rest-of-Latin America (RoLA) .................................................................. 161 10.6Rest-of-the-World .......................................................................................... 161 7 All rights reserved at BIS Research Inc.

  8. 11. Company Profiles .................................................................. 163 11.1 Overview ........................................................................................................... 164 11.2Thermo Fisher Scientific Inc. ........................................................................ 165 11.2.1Company Overview ................................................................................... 165 11.2.2Role of Thermo Fisher Scientific Inc. in the Global Organ Transplant Diagnostics Market .................................................................................... 165 11.2.3 Financials ................................................................................................... 166 11.2.3Key Insights About Financial Health of the Company ........................... 168 11.2.4SWOT Analysis .......................................................................................... 169 11.3QIAGEN N.V. ................................................................................................... 170 11.3.2Company Overview ................................................................................... 170 11.3.3Role of QIAGEN N.V. in the Global Organ Transplant Diagnostics Market ......................................................................................................... 170 11.3.4Financials ................................................................................................... 172 11.3.5Key Insights About Financial Health of the Company ........................... 173 11.3.6SWOT Analysis .......................................................................................... 174 11.4F. Hoffmann-La Roche Ltd. ........................................................................... 175 11.4.2Company Overview ................................................................................... 175 11.4.3Role of F. Hoffmann-La Roche Ltd in the Global Organ Transplant Diagnostics Market .................................................................................... 175 11.4.4Financials ................................................................................................... 177 Organ Transplant Diagnostics Market 11.4.5Key Insights About Financial Health of the Company ........................... 178 11.4.6SWOT Analysis .......................................................................................... 179 11.5Bio-Rad Laboratories, Inc. ............................................................................ 180 11.5.2Company Overview ................................................................................... 180 11.5.3Role of Bio-Rad Laboratories, Inc. in the Global Organ Transplant Diagnostics Market .................................................................................... 180 11.5.4Financials ................................................................................................... 181 8 All rights reserved at BIS Research Inc.

  9. 11.5.5Key Insights About Financial Health of the Company ........................... 183 11.5.6SWOT Analysis .......................................................................................... 184 11.6Laboratory Corporation of America Holdings ............................................. 185 11.6.2Company Overview ................................................................................... 185 11.6.3Role of Laboratory Corporation of America Holdings in the Global Organ Transplant Diagnostics Market ..................................................... 185 11.6.4Financials ................................................................................................... 186 11.6.5SWOT Analysis .......................................................................................... 188 11.7bioMérieux S.A. .............................................................................................. 189 11.7.2Company Overview ................................................................................... 189 11.7.3Role of bioMérieux S.A. in the Global Organ Transplant Diagnostics Market ......................................................................................................... 189 11.7.4Financials ................................................................................................... 190 11.7.5Key Insights About Financial Health of the Company ........................... 192 11.7.6SWOT Analysis .......................................................................................... 193 11.8CareDx, Inc. .................................................................................................... 194 11.8.2Company Overview ................................................................................... 194 11.8.3Role of CareDx, Inc. in the Global Organ Transplant Diagnostics Market ......................................................................................................... 194 11.8.4Financials ................................................................................................... 195 11.8.5Key Insights About Financial Health of the Company ........................... 197 Organ Transplant Diagnostics Market 11.8.6SWOT Analysis .......................................................................................... 198 11.9ARUP Laboratories ........................................................................................ 199 11.9.2Company Overview ................................................................................... 199 11.9.3Role of ARUP Laboratories in the Global Organ Transplant Diagnostics Market .................................................................................... 199 11.9.4SWOT Analysis .......................................................................................... 200 11.10Abbott Laboratories ...................................................................................... 201 9 All rights reserved at BIS Research Inc.

  10. 11.10.2 Company Overview ............................................................................. 201 11.10.3 Role of Abbott Laboratories in the Global Organ Transplant Market ......................................................................................................... 201 11.10.4 Financials ............................................................................................ 202 11.10.5 Key Insights About Financial Health of the Company ..................... 204 11.10.6 SWOT Analysis.................................................................................... 205 11.11Quest Diagnostics Incorporated .................................................................. 206 11.11.2 Company Overview ............................................................................. 206 11.11.3 Role of Quest Diagnostics Incorporated in the Global Organ Transplant Diagnostics Market ................................................................ 206 11.11.4 Financials ............................................................................................ 207 11.11.5 SWOT Analysis.................................................................................... 209 11.12Eurofins Scientific ......................................................................................... 210 11.12.2 Company Overview ............................................................................. 210 11.12.3 Role of Eurofins Scientific in the Global Organ Transplant Diagnostics Market .................................................................................... 210 11.12.4 Financials ............................................................................................ 211 11.12.5 SWOT Analysis.................................................................................... 212 11.13Illumina, Inc. ................................................................................................... 213 11.13.2 Company Overview ............................................................................. 213 11.13.3 Role of Illumina, Inc. in the Global Organ Transplant Organ Transplant Diagnostics Market Diagnostics Market .................................................................................... 213 11.13.4 Financials ............................................................................................ 214 11.13.5 Key Insights About Financial Health of the Company ..................... 216 11.13.6 SWOT Analysis.................................................................................... 217 11.14OPKO Health .................................................................................................. 218 11.14.2 Company Overview ............................................................................. 218 10 All rights reserved at BIS Research Inc.

  11. 11.14.3 Role of OPKO Health in the Global Organ Transplant Diagnostics Market .................................................................................... 218 11.14.4 Financials ............................................................................................ 219 11.14.5 Key Insights About Financial Health of the Company ..................... 220 11.14.6 SWOT Analysis.................................................................................... 221 11.15Novacyt Group ............................................................................................... 222 11.15.2 Company Overview ............................................................................. 222 11.15.3 Role of Novacyt Group in the Global Organ Transplant Diagnostics Market .................................................................................... 222 11.15.4 Financials ............................................................................................ 223 11.15.5 Key Insights About Financial Health of the Company ..................... 224 11.15.6 SWOT Analysis.................................................................................... 225 11.16Immucor, Inc, ................................................................................................. 226 11.16.2 Company Overview ............................................................................. 226 11.16.3 Role of Immucor, Inc. in the Global Organ Transplant Diagnostics Market .................................................................................... 226 11.16.4 SWOT Analysis.................................................................................... 227 Organ Transplant Diagnostics Market 11 All rights reserved at BIS Research Inc.

  12. List of Figures Figure 1: Figure 2: Figure: U.S. Solid Organ and Bone Marrow Transplant Procedures (2017-2020) Impact Analysis of Market Drivers and Market Challenges on the Global Organ Transplant Diagnostics Market Global Organ Transplant Diagnostics Market (by Offering), $Million, 2020 and 2031 Figure 3: Figure 4: Figure 5: Global Organ Transplant Diagnostics Market (by Transplant), $Million, 2020 and 2031 Global Organ Transplant Diagnostics Market (by Application), $Million, 2020 and 2031 Figure 6: Global Organ Transplant Diagnostics Market (by Technology), $Million, 2020 and 2031 Figure 7: Figure 8: Global Organ Transplant Diagnostics Market (by End Users), $Million, 2020 and 2031 Global Organ Transplant Diagnostics Market Snapshot Figure 9: Figure 10: Global Organ Transplant Diagnostics Market: Research Methodology Primary Research Methodology Figure 11: Figure 12: Bottom-Up Approach (Segment-Wise Analysis) Top-Down Approach (Segment-Wise Analysis) Figure 13: Global Organ Transplant Diagnostics Market Segmentation Figure 14: Figure 15: Global Organ Transplant Diagnostics Market, $Million, 2020-2031 Global Organ Transplant Diagnostics Market: COVID-19 Impact Analysis Figure 16: Figure 17: U.S. Solid Organ and Hematopoietic Stem Cell Transplant Data (2017-2020) Share of Key Developments and Strategies, January 2018-September 2021 Figure 18: Figure 19: Share of Synergistic Activities (by Company), January 2018-September 2021 Number of Product Launches (by Company), January 2018-September 2021 Figure 20: Share of Product Approvals (by Company), January 2018-September 2021 Figure 21: Figure 22: Share of Mergers and Acquisitions (by Company), January 2018–September 2021 Share of Other Business Activities (by Company), January 2018- September 2021 Figure 23: Market Share Analysis for Global Organ Transplant Diagnostics Market, $Million, 2019 and 2020 Figure 24: Growth Share Analysis for Global Organ Transplant Diagnostics Market (by Company), 2020 Figure 25: Figure 8.1: Global Organ Transplant Diagnostics Market (by Offering) Organ Transplant Diagnostics Market Figure 26: Figure 27: Global Organ Transplant Diagnostics Market (by Offering), 2020 and 2031 Global Organ Transplant Diagnostics Market (by Product), $Million, 2020-2031 Figure 28: Figure 29: Global Organ Transplant Diagnostics Market (Kits and Assays), 2020-2031 Global Organ Transplant Diagnostics Market (Consumables), $Million, 2020-2031 Figure 30: Global Organ Transplant Diagnostics Market (Services), $Million, 2020-2031 Figure 31: Global Organ Transplant Diagnostics Market (Transplant) 12 All rights reserved at BIS Research Inc.

  13. Figure 32: Figure 33: Global Organ Transplant Diagnostics Market (Transplant), 2020 and 2031 Global Organ Transplant Diagnostics Market (by Solid Organ Transplants), $Million, 2020- 2031 Global Organ Transplant Diagnostics Market (by Solid Organ Transplant), 2020 and 2031 Figure 34: Figure 35: Global Organ Transplant Diagnostics Market (Kidney, by Solid Organ Transplants), $Million, 2020-2031 Figure 36: Global Organ Transplant Diagnostics Market (Liver, by Solid Organ Transplants), $Million, 2020-2031 Figure 37: Global Organ Transplant Diagnostics Market (Heart, by Solid Organ Transplants), $Million, 2020-2031 Figure 38: Global Organ Transplant Diagnostics Market (Lung, by Solid Organ Transplants), $Million, 2020-2031 Figure 39: Global Organ Transplant Diagnostics Market (Pancreas, by Solid Organ Transplants), $Million, 2020-2031 Figure 40: Global Organ Transplant Diagnostics Market (Kidney-Pancreas, by Solid Organ Transplants), $Million, 2020-2031 Figure 41: Global Organ Transplant Diagnostics Market (Other Solid Organs, by Solid Organs), $Million, 2020-2031 Figure 42: Global Organ Transplant Diagnostics Market (Stem Cell Transplant), $Million, 2020-2031 Figure 43: Figure 44: Global Organ Transplant Diagnostics Market (by Application) Global Organ Transplant Diagnostics Market (by Application), $Million, 2020-2031 Figure 45: Figure 46: Global Organ Transplant Diagnostics Market (Diagnostics), $Million, 2020-2031 Global Organ Transplant Diagnostics Market (by Diagnostics), 2020 and 2031 Figure 47: Figure 48: Global Organ Transplant Diagnostics Market (Donor Testing), $Million, 2020-2031 Global Organ Transplant Diagnostics Market (by Donor Testing), 2020 and 2031 Figure 49: Global Organ Transplant Diagnostics Market (Infectious Disease, by Donor Testing), $Million, 2020-2031 Figure 50: Global Organ Transplant Diagnostics Market (Infectious Disease, by Donor Testing), 2020 and 2031 Figure 51: Global Organ Transplant Diagnostics Market (Viral, by Donor Testing), $Million, 2020- 2031 Organ Transplant Diagnostics Market Figure 52: Global Organ Transplant Diagnostics Market (Bacterial, by Donor Testing), $Million, 2020- 2031 Figure 53: Global Organ Transplant Diagnostics Market (Fungal, by Donor Testing), $Million, 2020- 2031 Figure 54: Global Organ Transplant Diagnostics Market (Parasitic, by Donor Testing), $Million, 2020- 2031 13 All rights reserved at BIS Research Inc.

  14. Figure 55: Global Organ Transplant Diagnostics Market (HLA Typing, by Donor Testing), $Million, 2020-2031 Figure 56: Global Organ Transplant Diagnostics Market (ABO Grouping, by Donor Testing), $Million, 2020-2031 Figure 57: Global Organ Transplant Diagnostics Market (Recipient Testing), $Million, 2020-2031 Figure 58: Figure 59: Global Organ Transplant Diagnostics Market (by Recipient Testing), 2020 and 2031 Global Organ Transplant Diagnostics Market (Infectious Disease, by Recipient Testing), $Million, 2020-2031 Figure 60: Global Organ Transplant Diagnostics Market (Infectious Disease, by Recipient Testing), 2020 and 2031 Figure 61: Global Organ Transplant Diagnostics Market (Viral, by Recipient Testing), $Million, 2020- 2031 Figure 62: Global Organ Transplant Diagnostics Market (Bacterial, by Recipient Testing), $Million, 2020-2031 Figure 63: Global Organ Transplant Diagnostics Market (Fungal, by Recipient Testing), $Million, 2020-2031 Figure 64: Global Organ Transplant Diagnostics Market (Parasitic, by Recipient Testing), $Million, 2020-2031 Figure 65: Global Organ Transplant Diagnostics Market (HLA Typing, by Recipient Testing), $Million, 2020-2031 Figure 66: Global Organ Transplant Diagnostics Market (ABO Grouping, by Recipient Testing), $Million, 2020-2031 Figure 67: Global Organ Transplant Diagnostics Market (Chimerism Testing, by Recipient Testing), $Million, 2020-2031 Figure 68: Global Organ Transplant Diagnostics Market (GvHD, by Recipient Testing), $Million, 2020-2031 Figure 69: Global Organ Transplant Diagnostics Market (Translational Research), $Million, 2020 – 2031 Figure 70: Figure 71: Global Organ Transplant Diagnostics Market (by Technology) Global Organ Transplant Diagnostics Market (by Technology), 2020 and 2021 Figure 72: Global Organ Transplant Diagnostics Market (Molecular Technologies), $Million, 2020- 2021 Organ Transplant Diagnostics Market Figure 73: Global Organ Transplant Diagnostics Market (by Molecular Technologies), 2020 and 2031 Figure 74: Figure 75: Global Organ Transplant Diagnostics Market (PCR), $Million, 2021-2031 Global Organ Transplant Diagnostics Market (by PCR), 2020 and 2031 Figure 76: Figure 77: Global Organ Transplant Diagnostics Market (RT-PCR, by PCR), $Million, 2020 and 2031 Global Organ Transplant Diagnostics Market (dPCR, by PCR), $Million, 2020 and 2031 Figure 78: Global Organ Transplant Diagnostics Market (Sequencing), $Million, 2020-2031 14 All rights reserved at BIS Research Inc.

  15. Figure 79: Figure 80: Global Organ Transplant Diagnostics Market (by Sequencing), 2020 and 2031 Global Organ Transplant Diagnostics Market (NGS, by Sequencing), $Million, 2020-2031 Figure 81: Global Organ Transplant Diagnostics Market (Sanger Sequencing, by Sequencing), $Million, 2020-2031 Figure 82: Global Organ Transplant Diagnostics Market (Other Molecular Technologies), $Million, 2020-2031 Global Organ Transplant Diagnostics Market (Serology), $Million, 2020-2031 Figure 83: Figure 84: Figure 85: Global Organ Transplant Diagnostics Market (Flow Cytometry), $Million, 2020-2031 Global Organ Transplant Diagnostics Market (Other Technologies), $Million, 2020-2031 Figure 86: Figure 87: Global Organ Transplant Diagnostics Market (by End User) Global Organ Transplant Diagnostics Market (by End User), $Million, 2020 and 2031 Figure 88: Global Organ Transplant Diagnostics Market (Hospitals and Transplant Centres), $Million, 2020-2031 Figure 89: Global Organ Transplant Diagnostics Market (Academic and Research Institutions), $Million, 2020-2031 Figure 90: Global Organ Transplant Diagnostics Market (Reference Laboratories), $Million, 2020- 2031 Global Organ Transplant Diagnostics Market (Other End Users), $Million, 2020-2031 Figure 91: Figure 92: Global Organ Transplant Diagnostics Market (by Region): Market Snapshot Figure 93: Figure 94: Global Organ Transplant Diagnostics Market (by Region), $Million, 2020-2031 Global Organ Transplant Diagnostics Market (by Region), 2020 and 2031 Figure 95: Figure 96: North America Organ Transplant Diagnostics Market, $Million, 2020-2031 North America: Market Dynamics Figure 97: Figure 98: North America Organ Transplant Diagnostics Market (by Country), $Million, 2020-2031 U.S. Organ Transplant Diagnostics Market, $Million, 2020-2031 Figure 99: Canada Organ Transplant Diagnostics Market, $Million, 2020-2031 Figure 100:Europe Organ Transplant Diagnostics Market, $Million, 2020-2031 Figure 101:Europe: Market Dynamics Figure 102:Europe Organ Transplant Diagnostics Market (by Country), $Million, 2020-2031 Figure 103:Germany Organ Transplant Diagnostics Market, $Million, 2020-2031 Organ Transplant Diagnostics Market Figure 104:France Organ Transplant Diagnostics Market, $Million, 2020-2031 Figure 105:U.K. Organ Transplant Diagnostics Market, $Million, 2020-2031 Figure 106:Italy Organ Transplant Diagnostics Market, $Million, 2020-2031 Figure 107:Spain Organ Transplant Diagnostics Market, $Million, 2020-2031 Figure 108:Switzerland Organ Transplant Diagnostics Market, $Million, 2020-2031 Figure 109:Rest-of-Europe Organ Transplant Diagnostics Market, $Million, 2020-2031 Figure 110:Asia-Pacific Organ Transplant Diagnostics Market, $Million, 2020-2031 15 All rights reserved at BIS Research Inc.

  16. Figure 111:APAC: Market Dynamics Figure 112:APAC Organ Transplant Diagnostics Market (by Country), $Million, 2020-2031 Figure 113:China Organ Transplant Diagnostics Market, $Million, 2020-2031 Figure 114:India Organ Transplant Diagnostics Market, $Million, 2020-2031 Figure 115:Japan Organ Transplant Diagnostics Market, $Million, 2020-2031 Figure 116:South Korea Organ Transplant Diagnostics Market, $Million, 2020-2031 Figure 117:Australia Organ Transplant Diagnostics Market, $Million, 2020-2031 Figure 118:Singapore Organ Transplant Diagnostics Market, $Million, 2020-2031 Figure 119:RoAPAC Organ Transplant Diagnostics Market, $Million, 2020-2031 Figure 120:Latin America Organ Transplant Diagnostics Market, $Million, 2020-2031 Figure 121:Latin America: Market Dynamics Figure 122:Global Organ Transplant Diagnostics Market (by Country), $Million, 2020-2031 Figure 123:Brazil Organ Transplant Diagnostics Market, $Million, 2020-2031 Figure 124:Mexico Organ Transplant Diagnostics Market, $Million, 2020-2031 Figure 125:RoLA Organ Transplant Diagnostics Market, $Million, 2020-2031 Figure 126:RoW Organ Transplant Diagnostics Market, $Million, 2020-2031 Figure 127:Total Number of Companies Profiled Figure 128:Thermo Fisher Scientific Inc.: Product Portfolio Figure 129:Thermo Fisher Scientific, Inc.: Overall Financials, 2018-2020 Figure 130:Thermo Fisher Scientific Inc.: Revenue (by Segment): 2018-2020 Figure 131:: Thermo Fisher Scientific Inc.: Revenue (by region), 2018-2020 Figure 132:Thermo Fisher Scientific Inc.: R&D Expenditure, 2018-2020 Figure 133:: Thermo Fisher Scientific Inc: SWOT Analysis Figure 134:QIAGEN N.V.: Product Portfolio Figure 135:QIAGEN N.V.: Overall Financials, 2018-2020 Figure 136:QIAGEN N.V.: Revenue (by Segment), 2018-2020 Figure 137:QIAGEN N.V.: Revenue (by Region), 2018-2020 Figure 138:QIAGEN N.V.: R&D Expenditure, 2018-2020 Figure 139:QIAGEN N.V.: SWOT Analysis Figure 140:F. Hoffmann-La Roche Ltd: Product Portfolio Organ Transplant Diagnostics Market Figure 141:F. Hoffmann-La Roche Ltd: Overall Financials, 2018-2020 Figure 142:F. Hoffmann-La Roche Ltd: Revenue (by Segment), 2018-2020 Figure 143:F. Hoffmann-La Roche Ltd.: Revenue (by Region), 2018-2020 Figure 144:F. Hoffmann-La Roche Ltd.: R&D Expenditure, 2018-2020 Figure 145:F. Hoffmann-La Roche Ltd: SWOT Analysis Figure 146:Bio-Rad Laboratories, Inc.: Product Portfolio Figure 147:: Bio-Rad Laboratories, Inc.: Overall Financials, 2018-2020 16 All rights reserved at BIS Research Inc.

  17. Figure 148:Bio-Rad Laboratories, Inc.: Revenue (by Segment), 2018-2020 Figure 149:Bio-Rad Laboratories, Inc.: Revenue (by Region), 2018-2020 Figure 150:Bio-Rad Laboratories, Inc.: R&D Expenditure, 2018-2020 Figure 151:Bio-Rad Laboratories, Inc.: SWOT Analysis Figure 152:Laboratory Corporation of America Holdings: Service Portfolio Figure 153:Laboratory Corporation of America Holdings: Overall Financials, 2018-2020 Figure 154:Laboratory Corporation of America Holdings: Revenue (by Segment), 2018-2020 Figure 155:Laboratory Corporation of America Holdings: SWOT Analysis Figure 156:bioMérieux S.A: Product Portfolio Figure 157:bioMérieux S.A.: Overall Financials, 2018-2020 Figure 158:bioMérieux S.A.: Revenue (by Segment), 2018-2020 Figure 159:bioMérieux S.A.: Revenue (by Region), 2018-2020 Figure 160:bioMérieux S.A.: R&D Expenditure, 2018-2020 Figure 161:bioMérieux S.A.: SWOT Analysis Figure 162:CareDx Inc.: Product Portfolio Figure 163:CareDx, Inc.: Overall Financials, 2018-2020 Figure 164:CareDx, Inc.: Revenue (by Segment), 2018-2020 Figure 165:CareDx, Inc.: Revenue (by Region), 2018-2020 Figure 166:CareDx, Inc.: R&D Expenditure, 2018-2020 Figure 167:CareDx, Inc., SWOT Analysis Figure 168:ARUP Laboratories: Product Portfolio Figure 169:ARUP Laboratories: SWOT Analysis Figure 170:Abbott Laboratories: Product Portfolio Figure 171:Abbott laboratories: Overall Financials, 2018-2020 Figure 172:Abbott Laboratories.: Revenue (by Segment), 2018-2020 Figure 173:Abbott Laboratories: Revenue (by Region), 2018-2020 Figure 174:Abbott Laboratories: R&D Expenditure, 2018-2020 Figure 175:Abbott Laboratories: SWOT Analysis Figure 176:Quest Diagnostics Incorporated: Product Portfolio Figure 177:Quest Diagnostics Incorporated: Overall Financials, 2018-2020 Organ Transplant Diagnostics Market Figure 178:Quest Diagnostics Incorporated: Revenue (by Segment), 2018-2020 Figure 179:Quest Diagnostics Incorporated: SWOT Analysis Figure 180:Eurofins Scientific: Service Portfolio Figure 181:Eurofins Scientific: Overall Financials, 2018-2020 Figure 182:Eurofins Scientific: Revenue (by Region), 2018-2020 Figure 183:Eurofins Scientific: SWOT Analysis Figure 184:Illumina Inc, Product Portfolio 17 All rights reserved at BIS Research Inc.

  18. Figure 185:Illumina, Inc, Overall Financials, 2018-2020 Figure 186:Illumina, Inc. Revenue (by Segment), 2018-2020 Figure 187:Illumina, Inc.: Revenue (by Region), 2018-2020 Figure 188:Illumina, Inc: R&D Expenditure, 2018-2020 Figure 189:Illumina, Inc: SWOT Analysis Figure 190:OPKO Health: Product Portfolio Figure 191:OPKO Health: Overall Financials, 2018-2020 Figure 192:OPKO Health: Revenue (by Region), 2018-2020 Figure 193:OPKO Health: R&D Expenditure, 2018-2020 Figure 194:OPKO Health: SWOT Analysis Figure 195:Novacyt Group: Product Portfolio Figure 196:Novacyt Group: Overall Financials, 2018-2020 Figure 197:Novacyt Group.: Revenue (by Segment): 2018-2020 Figure 198:Novacyt Group: R&D Expenditure, 2018-2020 Figure 199:Novacyt Group: SWOT Analysis Figure 200:Immucor, Inc: Product Portfolio Figure 201:Immucor, Inc.: SWOT Analysis Organ Transplant Diagnostics Market 18 All rights reserved at BIS Research Inc.

  19. List of Tables Table 1: Table 2: Key Coverage Providers for Organ Transplant Diagnostics Tests Likert Scale Table 3: Table 4: Impact Analysis of Market Drivers Impact Analysis of Market Restraints Table 5: Table 6: Companies Providing Kits and Assays: Companies Offering Consumables: Table 7: Table: Companies Offering Consumables: Table 8: Table 9: RT-PCR-Based Organ Transplant Diagnostic Products dPCR-Based Organ Transplant Diagnostic Products Table 10:NGS-Based Organ Transplant Diagnostic Products Table 11:Sanger Sequencing-Based Organ Transplant Diagnostic Products Table 12:Other Technologies-Based Organ Transplant Diagnostic Products Table 13:Serology-Based Organ Transplant Diagnostic Products Table 14:FCM-Based Organ Transplant Diagnostic Products Organ Transplant Diagnostics Market 19 All rights reserved at BIS Research Inc.

  20. Disclaimer BIS Research Inc. provides valuable market intelligence to an exclusive group of customers in response to orders. The report is licensed for the customer's internal use only and is subject to restrictions set henceforth. This document and its contents are confidential and may not be further distributed, published or reproduced, in whole or in part, by any medium or in any form for any purpose, without the express written consent of BIS Research Inc. Customer will not disclose the contents of the report, whether directly in any media or indirectly through incorporation in a database, marketing list, report or otherwise, or use or permit the use of Information to generate any statistical or other information that is or will be provided to third parties; or voluntarily produce Information in legal proceedings. Market reports are based on expectations, estimates and projections as of the date such information is available. Any recommendation contained in this report may not be suitable for all investors or businesses. The market conclusions drawn are necessarily based upon a number of estimates and assumptions that, while considered reasonable by BIS Research Inc. as of the date of such statements, are inherently subject to market fluctuations and business, economic and competitive uncertainties and contingencies For more details regarding permission, please contact us: Email: sales@bisresearch.com Tel: +1 510 404 8135 Organ Transplant Diagnostics Market 20 All rights reserved at BIS Research Inc.

  21. BIS RESEARCH INC. 39111 Paseo Padre PKWY, Suite 313 Fremont, CA 94538 -1686 Organ Transplant Diagnostics Market E-mail: hello@bisresearch.com | Call Us: +1-510-404-8135 Global Delivery Center Tower B First Floor, Tapasya Corporate Heights, Greater Noida Expressway, Sector 126, Noida, U.P., 201303, India Tel: +91 120 4261540 / 4261544 21 www.bisresearch.com All rights reserved at BIS Research Inc.

More Related